WEKO3
アイテム
{"_buckets": {"deposit": "84088e5f-bc8c-4a57-b650-670f7b43f838"}, "_deposit": {"created_by": 2, "id": "966", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "966"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00000966", "sets": ["11"]}, "author_link": ["4634", "4627", "4629", "4628", "4625", "4626", "4630", "4633", "4632", "4631"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2020-06-12", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "6", "bibliographicPageStart": "545", "bibliographicVolumeNumber": "12", "bibliographic_titles": [{"bibliographic_title": "Pharmaceutics"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "MicroRNAs in exosomes (exosomal miRNAs) are considered as significant targets for cancer therapy. Anti-miR oligonucleotides are often used for the functional inhibition of miRNAs; however, there are no studies regarding the regulation of exosomal miRNA functions. In this study, we attempted to develop a novel drug delivery system using anti-exosome antibody?anti-miR oligonucleotide complexes (ExomiR-Tracker) to hijack exosomes to carry anti-miR oligonucleotides inside exosome-recipient cells. We found that ExomiR-Tracker bound to the exosomes, and then the complexes were introduced into the recipient cells. We also found that anti-miR oligonucleotides introduced into the recipient cells can exhibit inhibitory effects on exosomal miRNA functions in vitro and in vivo. We believe that our strategy would be a promising one for targeting exosomal miRNAs.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Pharmaceutics, 12(6), art.no.545; 2020", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "MDPI"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.3390/pharmaceutics12060545", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/)."}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "19994923", "subitem_source_identifier_type": "ISSN"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Yamayoshi, Asako"}], "nameIdentifiers": [{"nameIdentifier": "4625", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Oyama, Shota"}], "nameIdentifiers": [{"nameIdentifier": "4626", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kishimoto, Yusuke"}], "nameIdentifiers": [{"nameIdentifier": "4627", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Konishi, Ryo"}], "nameIdentifiers": [{"nameIdentifier": "4628", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamamoto, Tsuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "4629", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kobori, Akio"}], "nameIdentifiers": [{"nameIdentifier": "4630", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Harada, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "4631", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ashihara, Eishi"}], "nameIdentifiers": [{"nameIdentifier": "4632", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sugiyama, Hiroshi"}], "nameIdentifiers": [{"nameIdentifier": "4633", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Murakami, Akira"}], "nameIdentifiers": [{"nameIdentifier": "4634", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-18"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "Pharmaceutics12_545.pdf", "filesize": [{"value": "7.7 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 7700000.0, "url": {"label": "Pharmaceutics12_545.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/966/files/Pharmaceutics12_545.pdf"}, "version_id": "cb4fdf28-4ce3-43a4-9ad4-d48e28a4903a"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Antibody", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Drug delivery system", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Exosome", "subitem_subject_scheme": "Other"}, {"subitem_subject": "MicroRNA", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Nucleic acid drug", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Development of Antibody?Oligonucleotide Complexes for Targeting Exosomal MicroRNA", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Development of Antibody?Oligonucleotide Complexes for Targeting Exosomal MicroRNA"}]}, "item_type_id": "2", "owner": "2", "path": ["11"], "permalink_uri": "http://hdl.handle.net/10069/40162", "pubdate": {"attribute_name": "公開日", "attribute_value": "2020-08-07"}, "publish_date": "2020-08-07", "publish_status": "0", "recid": "966", "relation": {}, "relation_version_is_last": true, "title": ["Development of Antibody?Oligonucleotide Complexes for Targeting Exosomal MicroRNA"], "weko_shared_id": -1}
Development of Antibody?Oligonucleotide Complexes for Targeting Exosomal MicroRNA
http://hdl.handle.net/10069/40162
http://hdl.handle.net/10069/40162e88f8193-d0ff-47fe-84b9-e09e0166197e
名前 / ファイル | ライセンス | アクション |
---|---|---|
Pharmaceutics12_545.pdf (7.7 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-08-07 | |||||
タイトル | ||||||
タイトル | Development of Antibody?Oligonucleotide Complexes for Targeting Exosomal MicroRNA | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Antibody | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Drug delivery system | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Exosome | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | MicroRNA | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Nucleic acid drug | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Yamayoshi, Asako
× Yamayoshi, Asako× Oyama, Shota× Kishimoto, Yusuke× Konishi, Ryo× Yamamoto, Tsuyoshi× Kobori, Akio× Harada, Hiroshi× Ashihara, Eishi× Sugiyama, Hiroshi× Murakami, Akira |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | MicroRNAs in exosomes (exosomal miRNAs) are considered as significant targets for cancer therapy. Anti-miR oligonucleotides are often used for the functional inhibition of miRNAs; however, there are no studies regarding the regulation of exosomal miRNA functions. In this study, we attempted to develop a novel drug delivery system using anti-exosome antibody?anti-miR oligonucleotide complexes (ExomiR-Tracker) to hijack exosomes to carry anti-miR oligonucleotides inside exosome-recipient cells. We found that ExomiR-Tracker bound to the exosomes, and then the complexes were introduced into the recipient cells. We also found that anti-miR oligonucleotides introduced into the recipient cells can exhibit inhibitory effects on exosomal miRNA functions in vitro and in vivo. We believe that our strategy would be a promising one for targeting exosomal miRNAs. | |||||
書誌情報 |
Pharmaceutics 巻 12, 号 6, p. 545, 発行日 2020-06-12 |
|||||
出版者 | ||||||
出版者 | MDPI | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 19994923 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.3390/pharmaceutics12060545 | |||||
権利 | ||||||
権利情報 | c 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Pharmaceutics, 12(6), art.no.545; 2020 |